CX Institutional Buys New Shares in The Cooper Companies, Inc. (NASDAQ:COO)

CX Institutional purchased a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,273 shares of the medical device company’s stock, valued at approximately $107,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Covestor Ltd increased its stake in shares of Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock valued at $42,000 after buying an additional 120 shares in the last quarter. Shell Asset Management Co. raised its stake in shares of Cooper Companies by 15.5% during the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company’s stock worth $87,000 after buying an additional 127 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company’s stock valued at $76,000 after purchasing an additional 129 shares during the period. Torray Investment Partners LLC boosted its holdings in Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after buying an additional 132 shares during the last quarter. Finally, Mitchell & Pahl Private Wealth LLC grew its holdings in Cooper Companies by 1.8% during the first quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company’s stock valued at $732,000 after purchasing an additional 157 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

COO has been the topic of several recent research reports. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $76.00 price target (down from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Thursday, May 22nd. Finally, Piper Sandler restated an “overweight” rating and issued a $105.00 price target (down previously from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $100.38.

Cooper Companies Price Performance

NASDAQ COO opened at $69.74 on Tuesday. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38. The stock has a 50-day moving average of $77.89 and a 200 day moving average of $85.89. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a market capitalization of $13.95 billion, a price-to-earnings ratio of 35.76, a PEG ratio of 2.25 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Cooper Companies’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.85 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.